chitosan has been researched along with Adverse Drug Event in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaad, GF; El-Dakroury, WA; El-Gizawy, SA; Shabana, ME; Zewail, MB | 1 |
| Akbari, V; Amirian, M; Jafari, N; Minaiyan, M; Rezazadeh, M; Rostami, M; Tabbakhian, M | 1 |
| Amin, MCIM; Buang, F; Jamil, A; Katas, H; Ng, SF; Siddique, MI; Zulfakar, MH | 1 |
| Bhumkar, D; Bodhankar, S; Dhar, S; Mali, V; Pokharkar, V; Prasad, BL | 1 |
| Anitha, A; Chennazhi, KP; Deepa, N; Jayakumar, R; Maya, S; Nair, SV | 1 |
5 other study(ies) available for chitosan and Adverse Drug Event
| Article | Year |
|---|---|
Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Chitosan; Clove Oil; Drug-Related Side Effects and Adverse Reactions; Leflunomide; Methotrexate; Rats; Surface-Active Agents; Tumor Necrosis Factor-alpha | 2023 |
A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies.
Topics: Animals; Cattle; Chitosan; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Glycerophosphates; Humans; Hydrogels; Rats; Rats, Sprague-Dawley; Stomatitis; Temperature | 2018 |
Minimization of Local and Systemic Adverse Effects of Topical Glucocorticoids by Nanoencapsulation: In Vivo Safety of Hydrocortisone-Hydroxytyrosol Loaded Chitosan Nanoparticles.
Topics: Animals; Chemistry, Pharmaceutical; Chitosan; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Hydrocortisone; Nanoparticles; Phenylethyl Alcohol; Rats; Rats, Wistar; Safety; Skin Cream; Skin Diseases | 2015 |
Acute and subacute toxicity studies of chitosan reduced gold nanoparticles: a novel carrier for therapeutic agents.
Topics: Animals; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug-Related Side Effects and Adverse Reactions; Female; Gold; Lethal Dose 50; Male; Materials Testing; Nanoparticles; Rats; Rats, Wistar; Survival Rate | 2009 |
Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Chitosan; Curcumin; Drug Carriers; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogen-Ion Concentration; Materials Testing; Mice; Muramidase; Nanoparticles; Particle Size | 2012 |